journal article·2025-12Open access

Harnessing biomaterials for tuning inflammation: A neutrophil-centric perspective

Qi-Hui Wang, Wen-Zhi Song, Chun-Yu Han, Shuang Yang, Sheng-Rui Gao, Yi-Cen Ai, Dezhou Wang, Yu-Tong Liu, Wan-Zhong Yin

Abstract

Inflammation is crucial in combating infection, tissue repair, and immune regulation. However, dysregulated inflammatory responses induce and exacerbate numerous systemic diseases, even posing life-threatening risks. Neutrophils, the most abundant white blood cells in the bloodstream, are vital to the innate immune system. In recent years, neutrophils have been discovered to exhibit phenotypic heterogeneity and functional plasticity, capable of regulating various biological processes and impacting human diseases. Furthermore, neutrophils and their derivatives can serve as natural sources for biomaterials to control inflammatory responses. In this timely review, we begin by outlining the complex functions of neutrophils in inflammatory responses. Subsequently, we summarize the design strategies for neutrophil-based biomaterials. Afterward, we list and analyze the advancements in neutrophil-based anti-inflammatory biomaterials. Finally, we explore the challenges and prospects in this area. This review aims to provide a comprehensive understanding of harnessing neutrophils as a therapeutic target.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Immune cells in cancer · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Inflammation and immune dysfunction in parkinson disease10.1038/s41577-022-00684-6 ↗
2. Emerging cell-free DNA scavenging biomaterials for inflammatory diseases: from mechanisms to therapies10.1016/j.actbio.2025.07.051 ↗
3. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease10.1038/s41581-022-00621-9 ↗
4. Design of therapeutic biomaterials to control inflammation10.1038/s41578-022-00426-z ↗
5. Interplay between inflammation and thrombosis in cardiovascular pathology10.1038/s41569-021-00552-1 ↗
6. The diverse roles of neutrophils from protection to pathogenesis10.1038/s41590-024-02006-5 ↗
7. Heterogeneity of neutrophils10.1038/s41577-019-0141-8 ↗
8. Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives10.1182/blood-2016-03-700336 ↗
9. Neutrophils as emerging therapeutic targets10.1038/s41573-019-0054-z ↗
10. Neutrophil heterogeneity: implications for homeostasis and pathogenesis10.1182/blood-2016-01-688887 ↗
11. The role of neutrophils in host defense and disease10.1016/j.jaci.2020.02.038 ↗
12. Neutrophil extracellular traps in immunity and disease10.1038/nri.2017.105 ↗
13. Intracellular DNA sensing by neutrophils and amplification of the innate immune response10.3389/fimmu.2023.1208137 ↗
14. Fcγ receptor heterogeneity in leukocyte functional responses10.3389/fimmu.2017.00280 ↗
15. Roles of neutrophil granule proteins in orchestrating inflammation and immunity10.1111/febs.15803 ↗
16. Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis10.1038/s44161-022-00108-7 ↗
17. The role of neutrophils in inflammation resolution10.1016/j.smim.2016.03.007 ↗
18. The cross-talk between mesenchymal stem cells and immune cells in tissue repair and regeneration10.3390/ijms22052472 ↗
19. Targeting neutrophils for cancer therapy
20. The discovery of blood cells
21. Paul ehrlich and the early history of granulocytes10.1128/microbiolspec.MCHD-0032-2016 ↗
22. Neutrophil chemoattractant receptors in health and disease: double-edged swords10.1038/s41423-020-0412-0 ↗
23. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor10.1073/pnas.82.5.1526 ↗
24. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm10.1016/0092-8674(94)90337-9 ↗
26. Targeting cuproplasia and cuproptosis in cancer10.1038/s41571-024-00876-0 ↗
27. Neutrophil extracellular traps kill bacteria10.1126/science.1092385 ↗
28. Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels10.1039/C3IB40175H ↗
29. Tailoring of albumin nanoparticles modified with mannose for effective targeting in immunosuppressive tumor microenvironment10.3390/micro5020030 ↗
30. Polarization of tumor-associated neutrophil phenotype by TGF-β:“N1” versus “N2” TAN10.1016/j.ccr.2009.06.017 ↗
31. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-110.1172/JCI57990 ↗
32. Marked alterations of neutrophil functions during sepsis-induced immunosuppression10.1189/jlb.4A0415-168RR ↗
33. Reprint of neutrophil cell surface receptors and their intracellular signal transduction pathways10.1016/j.intimp.2013.11.010 ↗
34. The structure and function of G-protein-coupled receptors10.1038/nature08144 ↗
35. G protein coupled pattern recognition receptors expressed in neutrophils: recognition, activation/modulation, signaling and receptor regulated functions10.1111/imr.13151 ↗
36. Structural mechanism underlying G protein family-specific regulation of G protein-gated inwardly rectifying potassium channel10.1038/s41467-019-10038-x ↗
37. C5L2: a controversial receptor of complement anaphylatoxin, C5a10.1096/fj.12-220509 ↗
38. Conformational variants of the ternary complex of C5a, C5aR1, and G-protein10.1080/07391102.2024.2305698 ↗
39. Activation of G-protein Gα subunits by receptors through Gα–Gβ and Gα–Gγ interactions10.1016/S0968-0004(02)00006-3 ↗
40. Leukotriene B4 receptors10.1016/S0090-6980(02)00056-4 ↗
41. Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE)10.1096/fj.201500117 ↗
42. Neutrophils recruited by leukotriene B4 induce features of plaque destabilization during endotoxaemia10.1093/cvr/cvy130 ↗
43. The neutrophil as a cellular source of chemokines10.1034/j.1600-065X.2000.17706.x ↗
44. Structural basis of CXC chemokine receptor 2 activation and signalling10.1038/s41586-020-2492-5 ↗
45. A guide to chemokines and their receptors10.1111/febs.14466 ↗
46. Multiple roles for chemokines in neutrophil biology10.3389/fimmu.2020.01259 ↗
47. Phospholipase C/protein kinase C pathway is essential for corneal re-epithelialization induced by Ap4A10.3109/02713683.2011.614371 ↗
48. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma10.1016/j.ygyno.2006.01.034 ↗
49. Role of JAK2/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors: a systemic review10.2147/JIR.S353489 ↗
50. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation10.1016/j.ajpath.2015.01.020 ↗
51. Formyl-peptide receptors in infection, inflammation, and cancer10.1016/j.it.2018.08.005 ↗
52. PI3K and negative regulation of TLR signaling10.1016/S1471-4906(03)00139-X ↗
53. Toll-like receptor signalling10.1038/nri1391 ↗
54. A single bacterial immune evasion strategy dismantles both MyD88 and TRIF signaling pathways downstream of TLR410.1016/j.chom.2015.11.006 ↗
55. Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals10.1080/08830185.2017.1380200 ↗
56. Current development of Fc gamma receptors (FcγRs) in diagnostics: a review10.1007/s11033-024-09877-9 ↗
57. Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo, blood
58. Transforming growth factor-β-activated kinase 1 is required for human FcγRIIIb-induced neutrophil extracellular trap formation10.3389/fimmu.2016.00277 ↗
59. Human neutrophil Fc gamma receptors: different buttons for different responses, J10.1093/jleuko/qiad080 ↗
60. β 2 integrin signaling Cascade in neutrophils: more than a single function10.3389/fimmu.2020.619925 ↗
61. Expression, role, and regulation of neutrophil Fcγ receptors10.3389/fimmu.2019.01958 ↗
62. Unlocking c-MET: a comprehensive journey into targeted therapies for breast cancer10.1016/j.canlet.2024.216780 ↗
63. Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products10.1186/s12943-018-0788-y ↗
64. The role of src kinase in macrophage-mediated inflammatory responses10.1155/2012/512926 ↗
65. Resolvin E1 and protectin D1 activate inflammation-resolution programmes10.1038/nature05877 ↗
66. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors10.1038/ni.1863 ↗
67. Mechanisms and treatment of organ failure in sepsis10.1038/s41581-018-0005-7 ↗
68. The immunopathology of sepsis and potential therapeutic targets10.1038/nri.2017.36 ↗
69. Neutrophils as emerging therapeutic targets10.1038/s41573-019-0054-z ↗
70. Necrotizing fasciitis: current concepts and review of the literature10.1016/j.jamcollsurg.2008.10.032 ↗
71. Evaluation and management of necrotizing soft tissue infections
72. Tissue damage from neutrophil-induced oxidative stress in COVID-1910.1038/s41577-020-0407-1 ↗
73. Characterization of low-density granulocytes in COVID-1910.1371/journal.ppat.1009721 ↗
74. Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19
75. The role of inhibitory receptors in monosodium urate crystal-induced inflammation10.3389/fimmu.2018.01883 ↗
76. Novel perception of neutrophil extracellular traps in gouty inflammation10.1016/j.intimp.2022.109642 ↗
77. Innate immunity in diabetes and diabetic nephropathy10.1038/nrneph.2015.175 ↗
78. PAR-4/Ca(2+)-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes10.1186/s12933-021-01267-w ↗
79. Vascular damage in systemic lupus erythematosus10.1038/s41581-023-00797-8 ↗
80. The role of neutrophils in rheumatic disease-associated vascular inflammation10.1038/s41584-021-00738-4 ↗
81. Spontaneous secretion of the citrullination enzyme PAD2 and cell surface exposure of PAD4 by neutrophils10.3389/fimmu.2017.01200 ↗
82. Neutrophils and redox stress in the pathogenesis of autoimmune disease10.1016/j.freeradbiomed.2018.03.049 ↗
83. Ultrathin hafnium disulfide atomic crystals with ROS-Scavenging and colon-targeting capabilities for inflammatory bowel disease treatment10.1021/acsnano.2c06151 ↗
84. European consensus on the histopathology of inflammatory bowel disease10.1016/j.crohns.2013.06.001 ↗
85. Targeting immune cell circuits and trafficking in inflammatory bowel disease10.1038/s41590-019-0415-0 ↗
86. Neutrophils: from IBD to the gut microbiota10.1038/s41575-023-00871-3 ↗
87. Engineering and targeting neutrophils for cancer therapy10.1002/adma.202310318 ↗
88. Engineering cells for cancer therapy10.1021/acs.accounts.4c00293 ↗
89. Isolation methods determine human neutrophil responses after stimulation10.3389/fimmu.2023.1301183 ↗
90. Isolation of mouse neutrophils
91. Neutrophil‐based drug delivery systems10.1002/adma.201706245 ↗
92. Neutrophil‐based delivery systems for nanotherapeutics10.1002/smll.201801674 ↗
93. Living leukocyte‐based drug delivery systems10.1002/adma.202207787 ↗
94. Neutrophil hitchhiking for drug delivery to the bone marrow10.1038/s41565-023-01374-7 ↗
95. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer10.1186/s13045-021-01141-y ↗
96. Therapeutically harnessing extracellular vesicles10.1038/s41573-022-00410-w ↗
97. Cell membrane-covered nanoparticles as biomaterials10.1093/nsr/nwz037 ↗
98. Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications
99. Supramolecular assemblies mimicking neutrophil extracellular traps for MRSE infection control10.1016/j.biomaterials.2020.120124 ↗
100. Nanotechnology reinforced neutrophil-based therapeutic strategies for inflammatory diseases therapy10.1016/j.nantod.2022.101577 ↗